87 related articles for article (PubMed ID: 19880538)
1. Role of matrix metalloproteinase-2 in the cardioprotective effect of ischaemic postconditioning.
Donato M; D'Annunzio V; Buchholz B; Miksztowicz V; Carrión CL; Valdez LB; Zaobornyj T; Schreier L; Wikinski R; Boveris A; Berg G; Gelpi RJ
Exp Physiol; 2010 Feb; 95(2):274-81. PubMed ID: 19880538
[TBL] [Abstract][Full Text] [Related]
2. Rosuvastatin given during reperfusion decreases infarct size and inhibits matrix metalloproteinase-2 activity in normocholesterolemic and hypercholesterolemic rabbits.
D'Annunzio V; Donato M; Erni L; Miksztowicz V; Buchholz B; Carrión CL; Schreier L; Wikinski R; Gelpi RJ; Berg G; Basso N
J Cardiovasc Pharmacol; 2009 Feb; 53(2):137-44. PubMed ID: 19188835
[TBL] [Abstract][Full Text] [Related]
3. Inhibiting matrix metalloproteinase-2 reduces protein release into coronary effluent from isolated rat hearts during ischemia-reperfusion.
Fert-Bober J; Leon H; Sawicka J; Basran RS; Devon RM; Schulz R; Sawicki G
Basic Res Cardiol; 2008 Sep; 103(5):431-43. PubMed ID: 18512095
[TBL] [Abstract][Full Text] [Related]
4. Duration of ischaemia determines matrix metalloproteinase-2 activation in the reperfused rabbit heart.
Prasan AM; McCarron HC; White MY; McLennan SV; Tchen AS; Hambly BD; Jeremy RW
Proteomics; 2002 Sep; 2(9):1204-10. PubMed ID: 12362337
[TBL] [Abstract][Full Text] [Related]
5. Hyperlipidemia attenuates the infarct size-limiting effect of ischemic preconditioning: role of matrix metalloproteinase-2 inhibition.
Giricz Z; Lalu MM; Csonka C; Bencsik P; Schulz R; Ferdinandy P
J Pharmacol Exp Ther; 2006 Jan; 316(1):154-61. PubMed ID: 16166272
[TBL] [Abstract][Full Text] [Related]
6. B-type natriuretic peptide at early reperfusion limits infarct size in the rat isolated heart.
Burley DS; Baxter GF
Basic Res Cardiol; 2007 Nov; 102(6):529-41. PubMed ID: 17896117
[TBL] [Abstract][Full Text] [Related]
7. Signalling pathways in ischaemic postconditioning.
Hausenloy DJ
Thromb Haemost; 2009 Apr; 101(4):626-34. PubMed ID: 19350104
[TBL] [Abstract][Full Text] [Related]
8. Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition.
Hönisch A; Theuring N; Ebner B; Wagner C; Strasser RH; Weinbrenner C
Basic Res Cardiol; 2010 Mar; 105(2):155-67. PubMed ID: 19842009
[TBL] [Abstract][Full Text] [Related]
9. Reduction in myocardial infarct size by postconditioning in patients after percutaneous coronary intervention.
Yang XC; Liu Y; Wang LF; Cui L; Wang T; Ge YG; Wang HS; Li WM; Xu L; Ni ZH; Liu SH; Zhang L; Jia HM; Vinten-Johansen J; Zhao ZQ
J Invasive Cardiol; 2007 Oct; 19(10):424-30. PubMed ID: 17906344
[TBL] [Abstract][Full Text] [Related]
10. Sevoflurane postconditioning converts persistent ventricular fibrillation into regular rhythm.
Zhang F; Chen G; Chen C; Yan M
Eur J Anaesthesiol; 2009 Sep; 26(9):766-71. PubMed ID: 19367168
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotection of sevoflurane postconditioning by activating extracellular signal-regulated kinase 1/2 in isolated rat hearts.
Chen HT; Yang CX; Li H; Zhang CJ; Wen XJ; Zhou J; Fan YL; Huang T; Zeng YM
Acta Pharmacol Sin; 2008 Aug; 29(8):931-41. PubMed ID: 18664326
[TBL] [Abstract][Full Text] [Related]
12. Endogenous nitric oxide (NO) protects against ischaemia-reperfusion injury in the rabbit.
Williams MW; Taft CS; Ramnauth S; Zhao ZQ; Vinten-Johansen J
Cardiovasc Res; 1995 Jul; 30(1):79-86. PubMed ID: 7553727
[TBL] [Abstract][Full Text] [Related]
13. The infarct size-limiting effect of ischemic postconditioning (IPOC) is suppressed in isolated hyperhomocysteinemic (Hhcy) rat hearts: the reasonable role of PKC-delta.
Rohilla A; Balakumar P
Biomed Pharmacother; 2009 Dec; 63(10):787-91. PubMed ID: 19914793
[TBL] [Abstract][Full Text] [Related]
14. Effect of nitrovasodilators and inhibitors of nitric oxide synthase on ischaemic and reperfusion function of rat isolated hearts.
du Toit EF; McCarthy J; Miyashiro J; Opie LH; Brunner F
Br J Pharmacol; 1998 Mar; 123(6):1159-67. PubMed ID: 9559900
[TBL] [Abstract][Full Text] [Related]
15. Modulation of cardioprotective effect of ischemic pre- and postconditioning in the hyperhomocysteinemic rat heart.
Balakumar P; Rohilla A; Singh G; Singh K; Singh M
Methods Find Exp Clin Pharmacol; 2009 Mar; 31(2):71-9. PubMed ID: 19455261
[TBL] [Abstract][Full Text] [Related]
16. Edaravone reduces myocardial infarct size and improves cardiac function and remodelling in rabbits.
Onogi H; Minatoguchi S; Chen XH; Bao N; Kobayashi H; Misao Y; Yasuda S; Yamaki T; Maruyama R; Uno Y; Arai M; Takemura G; Fujiwara H
Clin Exp Pharmacol Physiol; 2006 Nov; 33(11):1035-41. PubMed ID: 17042911
[TBL] [Abstract][Full Text] [Related]
17. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO
Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926
[TBL] [Abstract][Full Text] [Related]
18. Myocardial protection with postconditioning is not enhanced by ischemic preconditioning.
Halkos ME; Kerendi F; Corvera JS; Wang NP; Kin H; Payne CS; Sun HY; Guyton RA; Vinten-Johansen J; Zhao ZQ
Ann Thorac Surg; 2004 Sep; 78(3):961-9; discussion 969. PubMed ID: 15337028
[TBL] [Abstract][Full Text] [Related]
19. Infarct-sparing effect of myocardial postconditioning is dependent on protein kinase C signalling.
Zatta AJ; Kin H; Lee G; Wang N; Jiang R; Lust R; Reeves JG; Mykytenko J; Guyton RA; Zhao ZQ; Vinten-Johansen J
Cardiovasc Res; 2006 May; 70(2):315-24. PubMed ID: 16443207
[TBL] [Abstract][Full Text] [Related]
20. Ischaemic postconditioning protects isolated mouse hearts against ischaemia/reperfusion injury via sphingosine kinase isoform-1 activation.
Jin ZQ; Karliner JS; Vessey DA
Cardiovasc Res; 2008 Jul; 79(1):134-40. PubMed ID: 18334546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
